References
- Sheinson DM, Wong WB, Solon CE, et al. Estimated impact of public and private sector COVID-19 Diagnostics and treatments on us healthcare resource utilization. Adv Ther. 2021;38(2):1212–1226.
- Sharma B, Shahanshah MFH, Gupta S, et al. Recent advances in the diagnosis of COVID-19: a bird’s eye view. Expert Rev Mol Diagn. 2021;1–17. DOI:10.1080/14737159.2021.1874354
- Kumar M, Iyer SS. ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing. Expert Rev Mol Diagn. 2021;1–14. DOI:10.1080/14737159.2021.1902311
- Pathology AfM: SARS Cov-2. Molecular pathology survey. In: Association for molecular pathology. 2021. Available from: https://www.amp.org/advocacy/sars-cov-2-survey
- Mon-Lopez D, Garcia-Aliaga A, Gines Bartolome A, et al. How has COVID-19 modified training and mood in professional and non-professional football players? Physiol Behav. 2020;227:113148.
- Minucci A, Scambia G, De Bonis M, et al. BRCA testing delay during the COVID-19 pandemic: How to act? Mol Biol Rep. 2021;48(1):983–987.
- Langabeer SE. Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemic. Ir J Med Sci. 2021;190(1):27–28.
- Chowdhury P, Paul SK, Kaisar S, et al. COVID-19 pandemic related supply chain studies: a systematic review. Transp Res E Logist Transp Rev. 2021;148:102271.
- Becker G, Martin T, Sabo AN, et al. Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France. Eur Rev Med Pharmacol Sci. 2021;25(2):1158–1162.
- Affairs UNDoEaS. No one is safe, until everyone is. New York United Nations Department of Economic and Social Affairs; 2020. Available from: https://www.un.org/development/desa/en/news/sustainable/no-one-is-safe-until-everyone-is
- Ossom-Williamson P, Williams IM, Kim K, et al. Reporting and availability of COVID-19 Demographic data by us health departments (April to October 2020): Observational study. JMIR Public Health Surveill. 2021;7(4):e24288.
- Salathe M, Althaus C, Anderegg N, et al. Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland. Swiss Med Wkly. 2020;150:w20457.
- Udugama B, Kadhiresan P, Kozlowski HN, et al. Diagnosing COVID-19: The disease and tools for detection. ACS Nano. 2020;14(4):3822–3835.
- Matthews Q, Da Silva SJR, Norouzi M, et al. Adaptive, diverse and de-centralized diagnostics are key to the future of outbreak response. BMC Biol. 2020;18(1):153.
- Islam KU, Iqbal J. An update on molecular diagnostics for COVID-19. Front Cell Infect Microbiol. 2020;10:560616.
- Kubina R, Dziedzic A. Molecular and serological tests for COVID-19 a comparative review of SARS-CoV-2 Coronavirus laboratory and point-of-care diagnostics. Diagnostics (Basel). 2020;10(6):10.
- El Jaddaoui A,M, Raoui S, Sehli S, et al. A review on current diagnostic techniques for COVID-19. Expert Rev Mol Diagn. 2021;21(2):141–160.
- Wang C, Liu M, Wang Z, et al. Point-of-care diagnostics for infectious diseases: From methods to devices. Nano Today. 2021;37:101092.
- Roden AC, Bois MC, Johnson TF, et al. The spectrum of histopathologic findings in lungs of patients with fatal coronavirus disease 2019 (COVID-19) infection. Arch Pathol Lab Med. 2021;145(1):11–21.
- Sucharitha G, Gc DV.: Predicting the effect of Covid-19 by using Artificial Intelligence: A case study. Materials today: proceedings 2021, doi: 10.1016/j.matpr.2021.02.202 [ Epub ahead of print].
- Titus K: Keeping cool-headed in the face of SARS. CAP Today. Chicago, USA: College of American Pathologists, 2003.
- Harper K. The Fate of Rome: climate, disease, and the end of an empire. Princeton, New Jersey, USA: Princeton University Press. 2017. p.1–417.